04 Sep, 2024 Poland - Life Sciences Monthly Brief, August 2024 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our July monthly briefing, which covers key updates and insights in the following areas: Medicinal products;Medical...
04 Sep, 2024 Anticorruption and anti-money laundering top the UAE’s enforcement agenda: Key takeaways for the Life Sciences Sector By Adam Vause Celia Johnson-Morgan Katie Edwards Governments around the world continue to place corporate crime at the top of their enforcement agendas, and the United Arab Emirates...
08 Jan, 2024 Portugal | Removal of the retail price of medicines from labelling and packaging By Mariana Ricardo Since 2006, when the Medicines Code was approved in Portugal, marketing authorisation holders had to include the retail selling price of...
13 Dec, 2023 Experimental evidence in patent litigation – Rules for fair play By Rebecca Lawrence The technical nature of patent litigation means that experiments are often an essential (and sometimes the only) way to prove key aspects...
06 Oct, 2023 Poland - Life Sciences Monthly Brief, September 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our September monthly briefing for Poland, which covers key updates and insights in the following areas: Medicinal...
26 May, 2023 EU Pharma Law Revision: First Reactions and Next Steps By Marco de Morpurgo Laetitia Mouton Mary Foord-Weston Exactly one month ago, on 26 April 2023, the European Commission (EC) adopted its long-awaited proposal for the revision of the EU...
19 May, 2023 Brazilian Health Regulatory Agency updates regulation that governs requirements for clinical laboratory tests By Bruna Rocha Juliana Marcondes Victoria Cristofaro On May 3rd of this year, Anvisa approved Resolution No. 786/2023 ("RDC 786/2023"), which addresses the technical and health requirements...
28 Apr, 2023 The UK voluntary scheme for branded medicines pricing and access (VPAS): just what the doctor ordered, or a bitter pill to swallow? By Michael Stead Martha Pownall On the 1 April this year, amidst storm clouds gathering above the NHS in the form of staffing strikes, record waiting times and chronic...
20 Apr, 2023 Cross-border considerations for privacy in clinical trials - At the Intersection of Sciences and Law Podcast Series By James Clark Paula Gonzalez de Castejón Llano-Ponte David Kopans In this episode of At the Intersection of Sciences and Law Podcast Series, in light of the recent publication of our Cross-border Guide...
17 Apr, 2023 ESG Issues: Clinical Trials and Diversity (Racial Bias in Medical Technology) By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Abi Ketheeswaran Sharon Zhang +2 more... Show less ESG is increasingly a primary focus for companies and consumers alike. Across all industries, companies are under immense scrutiny from...
17 Apr, 2023 Inspirational Women in Life Sciences: Rebecca Lacey and Sonya Roy By Alexandra de Zwart In the third edition of our Cortex series on Inspirational Women in Life Sciences, we are delighted to feature two incredible Australian...
17 Apr, 2023 Plausibility of inventions: the decision of the EPO Enlarged Board of Appeal in G 2/21 By Massimiliano Tiberio Introduction On March 23rd, 2023, the Enlarged Board of Appeal of the EPO issued the long-awaited decision concerning the concept of...
04 Apr, 2023 You say “ed”, they say “ad”: The fine line between lawful educational campaigns and unlawful advertising of therapeutic goods in Australia By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Companies operating in the life sciences industry play a vital role in raising awareness of diseases and other medical conditions,...
17 Mar, 2023 FDA calls for comments on artificial intelligence in drug manufacturing By Keo Shaw Bethany Hills Daniel Tobey Geoffrey Levitt +1 more... Show less On March 1, 2023, FDA’s Center for Drug Evaluation and Research (CDER) published a discussion paper on artificial intelligence (AI) in...
14 Mar, 2023 Advertising therapeutic goods in Australia (don't let your ad make you sad) By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Due to a complex array of legislation, regulations and codes, advertising therapeutic goods in compliance with Australian law can be a...
10 Mar, 2023 Poland - Life Sciences monthly brief, February 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Medicinal productsClinical...